Merck Aktie WKN: 659990 / ISIN: DE0006599905

148,80EUR
+1,30EUR
+0,88%
16.04.2021
Diese Aktie kaufen
Werbung

Merck Aktien News

16.04.21
Novartis (NVS) Collaborates with Roche for API of RA Drug Actemra (Zacks)
16.04.21
Euractiv: Bulgaria Mulls Withdrawing AstraZeneca Jab (Novinite)
16.04.21
Pfizer doubles vaccines to Canada amid third wave (EN, Chinapost)
16.04.21
Top Research Reports for UnitedHealth, Pfizer & Accenture (Zacks)
16.04.21
Sanofi completes Kiadis acquisition (EN, Sanofi-Aventis)
16.04.21
Merck (MRK) Stops MK-7110 Development, Focuses on Molnupiravir (Zacks)
16.04.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
16.04.21
Colgate-Palmolive Webcasts 2021 First Quarter Earnings Conference Call April 30, 2021 - 8:30 a.m. ET (EN, Colgate-Palmolive)
16.04.21
H. B. Fuller (FUL) Hits 52-Week High, Can the Run Continue? (Zacks)
16.04.21
Here’s Why We Think Abbott Stock Will Rise Post Q1 (Forbes)
16.04.21
The Latest: Ukraine gets 117,000 Pfizer doses via COVAX (EN, Chinapost)
16.04.21
: Norway delays decision to ditch AstraZeneca vaccine, warning it could impact J&J rollout (MarketWatch)
16.04.21
Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S. (EN, Eli Lilly)
16.04.21
Covid-19 booster shot ‘likely’ needed within year, Pfizer chief says (Irish Times)
16.04.21
National Assembly: Democratic Bulgaria PG Proposes Overhaul of Election Code, Removal of Ivan Geshev (Novinite)
16.04.21
Ireland's most haunted home on market for a scary £2.3m (Belfast Telegraph)
16.04.21
Defense chief, Joint Chiefs of Staff chairman receive AstraZeneca vaccine shots (Korea Times)
16.04.21
New data for Roche’s OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis (Roche Holding AG)
16.04.21
F. Hoffmann-La Roche Ltd : New data for Roche’s OCREVUS (ocrelizumab) reinforce significant benefit on slowing disease progression in relapsing and primary progressive multiple sclerosis (Investegate)
16.04.21
GlaxoSmithKline hoping to deliver Australia’s next COVID treatment (The Sydney Morning Herald)
16.04.21
Pfizer chief says people will probably need yearly Covid booster (Financial Times)
15.04.21
Merkel Will Get AstraZeneca Vaccine (Novinite)
15.04.21
Why GlaxoSmithKline Stock Jumped Today (MotleyFool)
15.04.21
‘Slow’ UK response to AstraZeneca side-effects alarms experts (Financial Times)
15.04.21
Pfizer CEO: COVID-19 vaccine may require third dose within 12 months - CNET (Cnet)
15.04.21
Norway delays AstraZeneca vaccine ruling to further probe risks (Financial Times)
15.04.21
GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19 (EN, GlaxoSmithKline)
15.04.21
AstraZeneca: What's the deal with thrombosis? (Deutsche Welle)
15.04.21
London Markets: GlaxoSmithKline shares surge on report Elliott Management building a stake (MarketWatch)
15.04.21
Merck scraps two treatments for hospitalized COVID-19 patients, will focus on antiviral for non-hospitalized patients (Market Watch)
15.04.21
The Zacks Analyst Blog Highlights: Abbott, Salesforce, BHP Group, Danaher and Zoom Video (Zacks)
15.04.21
Zacks.com featured highlights include: Balchem Corp, Civista Bancshares, H.B. Fuller and Nexstar Media Group (Zacks)
15.04.21
Blood clots as prevalent with Pfizer and Moderna vaccine as with AstraZeneca's: study (Market Watch)
15.04.21
Could This Cheap COVID Vaccine Spell Doom for Pfizer and Moderna? (MotleyFool)
15.04.21
EU puts faith in Pfizer jab with plan for 1.8 billion doses (Deutsche Welle)
15.04.21
Coronavirus digest: Denmark halts AstraZeneca vaccination indefinitely (Deutsche Welle)
15.04.21
Some 18,000 people register for vaccinations so far, HSE says (Irish Times)
15.04.21
LANXESS Aktiengesellschaft : Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (Investegate)
15.04.21
Roche’s Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA) (Roche Holding AG)
15.04.21
F. Hoffmann-La Roche Ltd : Roche’s Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA) (Investegate)
Seite: 123456789...25

Merck News

Merck News: auf dieser Seite finden Sie alle Merck News und Nachrichten zur Merck Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Merck News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Merck News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln